Psychedelic microdosing: A new frontier for treating ADHD symptoms and emotional dysregulation
A new study published in the journal European Psychiatry has shed light on an unconventional approach to managing symptoms associated with Attention-Deficit Hyperactivity Disorder (ADHD). The findings suggest that small, repeated doses of substances like psilocybin and lysergic acid diethylamide (LSD) could potentially help reduce ADHD symptoms and enhance some aspects of emotion regulation. These findings could pave the way for new treatments that focus not only on the primary symptoms of ADHD but also on improving emotional and social functioning.
Other Articles in this Edition
ADHD often goes undetected in adults, experts say
Staying Fit Boosts Kids’ Mental Health
Decision-making deficits predict social difficulties in children with ADHD
Inhibition in ADHD: Girls Are Slow to Respond, Boys Have Poor Cognitive Control
Psychedelic microdosing: A new frontier for treating ADHD symptoms and emotional dysregulation
A deep dive into Qbtech’s diagnostic ADHD test
Off-Label Use of ADHD Medications for Patients With Bipolar Disorder
Connections Between Food Additives and Psychiatric Disorders
Tris Digital Health Forms, Will Focus on Digital Diagnostic Platform for ADHD
How to improve focus: Try these 5 tips to increase attention span